CatalystWireBeta

UK small-cap RNS · 26 Jun 2026

Every announcement of UK small & mid caps under £2bn. The ones that started or moved a situation are marked – a click opens it.

Sort: Newest · Largest companies
  1. 15:25
    Delay to Publication of 31 Dec 2025 Results Results
    Caspian Sunrise PLC ("Caspian Sunrise" or the "Group")
    −7.1% on the day
  2. 11:00
    Annual Report and Notice of AGM Results
    Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company, pioneering, specialist neonatal intensive care medical devices, announces that the Annual Report and Accounts for the year ended 31 January 2026 and the Notice of Annual …
    −4.4% on the day
  3. 07:21
    Audited 2025 Annual Report and Notice of AGM Results
    Audited FY25 accounts match the 15 June figures: EBITDA down 54% to USD 42.7m after the Search reset, with a USD 41.7m Search impairment. Nothing new, and 2026 expectations are only reiterated.
    in lineoutlook positive +0.9% on the day
  4. 07:00
    Results of Fundraising Results
    The placing completed at 1p, a 24.81% discount to the prior close, issuing 400m shares and lifting the share count to about 2.87bn. It funds a pre-revenue company but dilutes holders heavily.
    Dilutive fundraise £4.0m · 25% of mcap −4.1% on the day
    Moved: Discounted placing of up to £4m: Accelerated bookbuild launched; broker offer open → Placing completed, oversubscribed; admission pending
  5. 07:00
    Investor Presentation covering Full Year Results Results
    Polar Capital Holdings plc ("Polar Capital" or the "Group"), the specialist active asset management group, is pleased to announce that Iain Evans, CEO, and Samir Ayub, CFO, will be conducting a live online presentation covering the Group's results for the …
    −0.6% on the day
  6. 07:00
    Final Results Results
    Arc Minerals (LSE: ARCM), an exploration company focused on discovering and developing Tier 1 copper deposits in Africa, is pleased to announce its Final Results for the year ended 31 December 2025.
    first in 9 months −19.0% on the day
  7. 07:00
    2025 Full Year Results Results
    Full-year results for the year ended 31 December 2025
    first in 9 months +0.0% on the day
  8. 07:00
    Final Results Results
    Loss widened to £1.90m from £0.61m as R&D rose to £908k ahead of the Phase 2 trial; cash was £1.13m at year end, but regulatory milestones were met and funding has since been added.
    Project milestones £2.7m · 39% of mcapoutlook mixed, loweredfirst in 9 months +0.0% on the day
    Moved: Irinotecan-ChemoSeed glioblastoma Phase 2: First batch made; dosing guided to H1 2026 → Funded; manufacturing done, site activation advanced
  9. 07:00
    Annual Report Results
    Final results for the year ended 31 December 2025
    −1.7% on the day
  10. 07:00
    Results for the year ended 31 March 2026 Results
    FY26 results match the revenue given on 8 April and EBITDA in line with market expectations. The Board adds no numeric guidance, only confidence in FY27 growth, so this is not a raise.
    Balance-sheet stress / refinancing £6.0m · 71% of mcapin lineoutlook positivefirst since Oct 2023 +0.0% on the day
    Moved: Going concern and cash runway: FY26 revenue in range; cash £2.0m → FY26 results: cash £2.0m, no debt · Pricing and cost reset: Box Clever in progress; subscription launched → Initial savings achieved early FY27

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note